Literature DB >> 19880814

Increase in oral cancer drugs raises thorny issues for oncology practices.

Karyn Hede.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19880814     DOI： 10.1093/jnci/djp421

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

Review 1.  Interventions to promote adherence with oral agents.

Authors:  Susan M Schneider; Kimberly Hess; Tracy Gosselin
Journal:  Semin Oncol Nurs       Date:  2011-05       Impact factor: 2.315

2.  The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer.

Authors:  Dawn L Hershman; Jennifer Tsui; Jay Meyer; Sherry Glied; Grace Clarke Hillyer; Jason D Wright; Alfred I Neugut
Journal:  J Natl Cancer Inst       Date:  2014-10-27       Impact factor: 13.506

3.  Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer.

Authors:  Alfred I Neugut; Milayna Subar; Elizabeth Ty Wilde; Scott Stratton; Corey H Brouse; Grace Clarke Hillyer; Victor R Grann; Dawn L Hershman
Journal:  J Clin Oncol       Date:  2011-05-23       Impact factor: 44.544

4.  Cancer patients' use of pharmaceutical patient assistance programs in the outpatient pharmacy at a large tertiary cancer center.

Authors:  Tisha M Felder; Lincy S Lal; Charles L Bennett; Frank Hung; Luisa Franzini
Journal:  Community Oncol       Date:  2012-02-10

5.  2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy.

Authors:  Michael N Neuss; Martha Polovich; Kristen McNiff; Peg Esper; Terry R Gilmore; Kristine B LeFebvre; Lisa Schulmeister; Joseph O Jacobson
Journal:  J Oncol Pract       Date:  2013-03       Impact factor: 3.840

6.  Impact of the healthcare payment system on patient access to oral anticancer drugs: an illustration from the French and United States contexts.

Authors:  Laure Benjamin; Valérie Buthion; Gwenaëlle Vidal-Trécan; Pascal Briot
Journal:  BMC Health Serv Res       Date:  2014-06-20       Impact factor: 2.655

7.  Impact of pharmacy channel on adherence to oral oncolytics.

Authors:  Michael Stokes; Carolina Reyes; Yu Xia; Veronica Alas; Hans-Peter Goertz; Luke Boulanger
Journal:  BMC Health Serv Res       Date:  2017-06-19       Impact factor: 2.655

Review 8.  Oral cancer therapy: policy implications for the uninsured and underinsured populations.

Authors:  Beth Faiman
Journal:  J Adv Pract Oncol       Date:  2013-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.